Miguel López-Botet

Author PubWeight™ 40.31‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. Blood 2004 3.36
2 Human cytomegalovirus infection is associated with increased proportions of NK cells that express the CD94/NKG2C receptor in aviremic HIV-1-positive patients. J Infect Dis 2006 2.49
3 Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts. Blood 2005 2.40
4 Influence of congenital human cytomegalovirus infection and the NKG2C genotype on NK-cell subset distribution in children. Eur J Immunol 2012 1.72
5 NKp46 and DNAM-1 NK-cell receptors drive the response to human cytomegalovirus-infected myeloid dendritic cells overcoming viral immune evasion strategies. Blood 2010 1.38
6 Expression and function of NKG2D in CD4+ T cells specific for human cytomegalovirus. Eur J Immunol 2006 1.35
7 The human cytomegalovirus MHC class I homolog UL18 inhibits LIR-1+ but activates LIR-1- NK cells. J Immunol 2007 1.29
8 Influence of human cytomegalovirus infection on the NK cell receptor repertoire in children. Eur J Immunol 2010 1.17
9 CMV and Immunosenescence: from basics to clinics. Immun Ageing 2012 1.17
10 Differential effects of US2, US6 and US11 human cytomegalovirus proteins on HLA class Ia and HLA-E expression: impact on target susceptibility to NK cell subsets. Eur J Immunol 2003 1.10
11 IREM-1 is a novel inhibitory receptor expressed by myeloid cells. Eur J Immunol 2004 1.09
12 IL-12-dependent inducible expression of the CD94/NKG2A inhibitory receptor regulates CD94/NKG2C+ NK cell function. J Immunol 2009 1.07
13 Human T cell receptor-mediated recognition of HLA-E. Eur J Immunol 2002 1.06
14 Natural killer cell-mediated response to human cytomegalovirus-infected macrophages is modulated by their functional polarization. J Leukoc Biol 2011 1.03
15 The IREM-1 (CD300f) inhibitory receptor associates with the p85alpha subunit of phosphoinositide 3-kinase. J Immunol 2007 1.03
16 Adaptive reconfiguration of the human NK-cell compartment in response to cytomegalovirus: a different perspective of the host-pathogen interaction. Eur J Immunol 2013 1.02
17 The CD94/NKG2C killer lectin-like receptor constitutes an alternative activation pathway for a subset of CD8+ T cells. Eur J Immunol 2005 1.02
18 Molecular characterization of a novel immune receptor restricted to the monocytic lineage. J Immunol 2004 0.99
19 Inhibition of NKG2D expression in NK cells by cytokines secreted in response to human cytomegalovirus infection. Blood 2010 0.99
20 NKG2C zygosity influences CD94/NKG2C receptor function and the NK-cell compartment redistribution in response to human cytomegalovirus. Eur J Immunol 2013 0.98
21 Host genetic factors in susceptibility to herpes simplex type 1 virus infection: contribution of polymorphic genes at the interface of innate and adaptive immunity. J Immunol 2012 0.94
22 Human KIR2DL5 is an inhibitory receptor expressed on the surface of NK and T lymphocyte subsets. J Immunol 2007 0.94
23 Gender-associated differences of perforin polymorphisms in the susceptibility to multiple sclerosis. J Immunol 2010 0.91
24 Recruitment of C-terminal Src kinase by the leukocyte inhibitory receptor CD85j. Biochem Biophys Res Commun 2004 0.90
25 Differential expression of inhibitory and activating CD94/NKG2 receptors on NK cell clones. J Immunol Methods 2002 0.90
26 Functional analysis of the CD300e receptor in human monocytes and myeloid dendritic cells. Eur J Immunol 2010 0.89
27 Mutational analysis of immunoreceptor tyrosine-based inhibition motifs of the Ig-like transcript 2 (CD85j) leukocyte receptor. J Immunol 2002 0.88
28 KIR2DL5: An Orphan Inhibitory Receptor Displaying Complex Patterns of Polymorphism and Expression. Front Immunol 2012 0.86
29 Signalling via CD70, a member of the TNF family, regulates T cell functions. J Leukoc Biol 2004 0.83
30 Concentrations of cyclosporin A and FK506 that inhibit IL-2 induction in human T cells do not affect TGF-beta1 biosynthesis, whereas higher doses of cyclosporin A trigger apoptosis and release of preformed TGF-beta1. J Leukoc Biol 2005 0.83
31 The human cytomegalovirus-specific UL1 gene encodes a late-phase glycoprotein incorporated in the virion envelope. J Virol 2012 0.82
32 Association of atherosclerosis with expression of the LILRB1 receptor by human NK and T-cells supports the infectious burden hypothesis. Arterioscler Thromb Vasc Biol 2011 0.82
33 Priming of NK cell anti-viral effector mechanisms by direct recognition of human cytomegalovirus. Front Immunol 2013 0.80
34 Cloning of two new splice variants of Siglec-10 and mapping of the interaction between Siglec-10 and SHP-1. Biochem Biophys Res Commun 2002 0.80
35 Expansion of the NKG2C+ natural killer-cell subset is associated with high-risk carotid atherosclerotic plaques in seropositive patients for human cytomegalovirus. Arterioscler Thromb Vasc Biol 2013 0.79
36 Natural killer cell receptor expression reflects the role of human cytomegalovirus in the pathogenesis of a subset of CD4+ T-cell large granular lymphocytosis. Hum Immunol 2010 0.75